SLC2A4 and obesity disorder: AP also reduced hyperglycemia and hyperinsulinemia by increasing adiponectin secretion and suppressing TNF-α secretion by white adipocytes, and elevating the expression of GLUT4 in skeletal muscle in addition to reducing obesity.